AstraZeneca PLC (AZN)
188.50
+5.10
(+2.78%)
USD |
NYSE |
Mar 27, 16:00
189.05
+0.55
(+0.29%)
After-Hours: 19:17
AstraZeneca EPS Diluted (Quarterly) : 0.743 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 0.414 |
| Mereo BioPharma Group Plc | -0.0461 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.326B |
| Revenue (Quarterly) | 15.48B |
| Total Expenses (Quarterly) | 13.16B |
| Enterprise Value | 308.25B |
| Gross Profit Margin (Quarterly) | 72.19% |
| Profit Margin (Quarterly) | 15.02% |
| Earnings Yield | 1.74% |
| Operating Earnings Yield | 2.31% |
| Normalized Earnings Yield | 1.767 |